Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 202615 Citations
BPC-157 is the most popular healing peptide in the world, backed by 180+ PubMed papers and consistent user reports from tens of thousands of people. Community evidence for tendon and gut repair is hard to dismiss, though formal human trials remain limited to about 30 subjects total.
250mcg · 2x Daily
Summary: Add 2mL BAC water to your 5mg vial. Draw to 10.0 units on a U-100 syringe for a 250mcg dose. This vial will last 20 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 250mcg | 2x Daily |
| Moderate | 500mcg | Daily |
| Aggressive | 500mcg | 2x Daily |
All dosing is community-driven. No human dose-finding trial has been completed. The tiers: beginner 250 mcg twice daily, moderate 500 mcg once daily, aggressive 500 mcg twice daily. All subcutaneous. For gut healing, 500 mcg oral once daily on an empty stomach. Reconstitution: 5 mg vial with 2 mL bacteriostatic water gives 2.5 mg per mL. Each 10 units on a U-100 insulin syringe equals 250 mcg. A 10 mg vial with 2 mL: each 5 units equals 250 mcg. Add water along the vial wall; swirl, never shake. Inject as close to the injury as you can. For gut applications, take orally on an empty stomach and wait 30 minutes. Cycle 4 to 6 weeks on, 2 weeks off. Refrigerate reconstituted vials at 2 to 8 degrees Celsius; use within 3 to 4 weeks. BPC-157 is prohibited under WADA S0 in and out of competition.
Dosing based on Community dosing consensus from peptide research communities — 18 published references.View all sources →
Cross-check your BPC-157 reconstitution math with AI
500mcg recommended dosage, 10 AM/PM daily, 8 weeks on / 8 weeks off.
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
BPC-157 is the most popular healing peptide in the world, backed by 180+ PubMed papers and consistent user reports from tens of thousands of people. Community evidence for tendon and gut repair is hard to dismiss, though formal human trials remain limited to about 30 subjects total.